Polymorphisms within the coding or promoter regions of the TLR4 gene can modify the receptor’s responsiveness to lipopolysaccharides (LPS), enhancing immune and inflammatory signaling and thereby contributing to the development of obesity and related metabolic disorders. The gene discussed is TLR4; the disease is obesity disorder.